- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
FDC Limited — Updates, 05-08-2026: Press Release
05-08-2026 | 06:10 pm
05-08-2026 | 06:10 pm
FDC's Q1 FY27 revenue rose 3% to Rs 668 Cr, with PAT up 9.2% to Rs 132 Cr. Strong international formulation sales (+74.2% Y-o-Y), driven by the US business (+118.4%), offset subdued domestic and API segments. The company secured US FDA approval for Cefixime.
No comments yet. Be the first to comment!